Kevin C. Berryman
Analyst · KeyBanc
Thank you, Matthias, and good morning, and good afternoon, everyone. I'd like to turn back to our consolidated results. And on the slide, you can see that we delivered again strong operating metrics again in the second quarter on a consolidated basis. Our net sales of $788 million were up 4% on a reported basis and also on a local currency basis. Our consolidated sales includes the results from Aromor, which added a percentage point to our consolidated growth. This quarter, Fragrances comprised 52% of our sales and Flavors, the remaining 48%. Our growth was the result of our diversity in terms of regions, end-use categories and customers. Emerging markets grew 5% this quarter and the developed markets declined by 1%, reflecting a challenging environment in North America for Flavors and a slower growth in Fine Fragrance in Western Europe during the second quarter. Our adjusted gross margin this quarter improved by 90 basis points to 45.1%. This primarily reflects gross margin expansion in Fragrance due to volume gains, certainly a result of strong new wins, currency benefits, as well as the favorable impact of price to input costs and internal improvement initiatives across both business units. The strong margin growth combined with lower incentive compensation and favorable currency resulted in an 8% increase in our adjusted operating profit to $156 million, resulting again in our operating profit margin rising to 19.8%, up 60 basis points from the year-ago figure of 19.2%. Our adjusted effective tax rate in the second quarter of 24.9% was favorable to our adjusted figure of 26.5% in the first quarter of 2013, reflecting higher earnings from lower tax jurisdictions and the effect of favorable tax settlements, partially offset by higher repatriation costs and the absence of the R&D tax credit in the current quarter. The strong operating profit growth, when combined with foreign exchange gains, lower interest expense and the positive impact on earnings per share of our share repurchase program, this resulted in a year-over-year improvement of 21% in our [indiscernible] $1.37. Importantly, the growth in all of our profitability metrics in the second quarter are all at or above our long-term growth targets. Now that we are halfway into the year, I wanted to put things into perspective by looking at our operating performance for the first half of 2014. It's important to note that on a year-to-date basis, all of our growth targets are in line with or above our long-term growth targets. Our net sales of $1.6 billion increased 5% on both a reported and local currency basis, and of course, that includes approximately 1 percentage point of growth from Aromor. This is clearly within our long-term growth target of 4% to 6% organic growth. Our adjusted gross margins also increased 130 basis points to 44.9%. Regarding adjusted operating profit, it increased 11% in the first 6 months of 2014, reflecting in part lower incentive compensation accruals. This equates to 110 basis point improvement in our operating profit to 20.2%. Finally, our adjusted diluted EPS increased 16% to $2.69 for the first 6 months of 2014, ahead of our long-term growth targets. Turning to our research, selling and administrative costs. RSA, as a percent of sales, increased 30 basis points from 25% of sales to 25.3% of sales or an increase of $10 million. The primary drivers of the increase include Aromor-related cost, including operating and amortization and acquisition costs, investment in commercial resources to support our 3-pillar strategy, currency impacts and several discrete items. These higher expenses were partially offset by reduced incentive compensation accruals versus the very high levels in the second quarter of a year ago. We remain focused on maintaining cost discipline while investing in R&D and other strategic growth opportunities. This quarter, R&D spending was 8.4% of sales versus 8.5% in the prior year. The prior year figure, as you may recall, includes an initial payment to Amyris, as well as other investments in research and development. Importantly, our emphasis on R&D has resulted in a stronger pipeline of innovation, and we continue to invest in our R&D platforms and the programs that support them. Our strong cash flow position and margins provides us with the continued flexibility to do so. Turning to currency. Here, you see our customary chart showing the change and the strength of the euro relative to the dollar as the movement in the euro represents the large variable relative to currency impact on our results. As noted earlier, foreign exchange movements had a negligible impact on our top line growth. As it relates to our adjusted operating profit and EPS results for the quarter, year-over-year currency impacts were positive. And at the operating profit line, we continue to proactively manage our gross margin profile through our cash flow hedging programs. During Q2, we specifically benefited from a stronger U.S. dollar versus several of the emerging market currencies, which favorably impacted local expenses. Finally, EPS growth also benefited from the absence of foreign exchange losses and working capital, which we experienced in the second quarter of 2013 due to the high level of volatility in foreign exchange markets in the second quarter of last year. As a reminder, the 2014 -- for 2014, the majority of our euro exposure continues to be hedged at a rate of 1.32%, close to the full year average of 2013. Turning to our cash flow. Our operating cash flow in the first half of 2014 was $154 million compared with an operating cash flow of $118 million in the prior year quarter. The prior year cash flow included a $30 million incremental U.S. pension contribution and the year-over-year increase reflects the $34 million improvement in net income, partially offset by increased incentive compensation payments in the first quarter of 2014 versus the first quarter of 2013. As a percent of sales, the current quarter operating cash flow is 9.9% of sales compared with 7.9% in the year-ago quarter. Core working capital increased in absolute dollars to support business growth, however, declined on a percentage of sales basis and is on-track for targeted improvements that we outlined at the beginning of the year. Turning to our capital structure. Capital spending for growth and infrastructure and newer technology continues to be our most important use of cash. Over the past 3 years, we have been investing approximately 4.5% of sales on adding capacity where it's needed to optimize our geographic footprint and to ensure that our proprietary technologies are available to our customers around the globe. We are also committed to returning capital to our shareholders in the form of dividends and share repurchases. Yesterday, our Board of Directors authorized a 21% increase or $0.08 in the quarterly dividend to $0.47 per share, up from the $0.39 per share a year ago. This dividend is payable on October 7 to shareholders of record as of September 25. Including this authorization, IFF's quarterly dividend payment will have grown by a compound annual growth rate of 15% over the last 4 years. The current authorization importantly reflects the board's confidence in the company's ability to continue to execute on its 3-pillar strategy based on the notable progress we've made in expanding our geographic footprint, developing our R&D pipeline and improving the margin profile of our portfolio. The double-digit increase in the dividend also reflects our strong cash flow position. This enables us to maintain a competitive dividend yield, continue to execute against our share buyback program, all while maintaining a strong amount of financial flexibility to aggressively explore M&A opportunities. Regarding our share buyback program. On a year-to-date basis, we have spent approximately $34 million on share buybacks. Total program spending since the first quarter of 2013 is $86 million through the end of the second quarter. Based on our programmatic share buyback program, we continue to expect that we will spend more on share buybacks in 2014 than we did in 2013. Finally, as noted, we continue to evaluate business development opportunities. We are targeting those opportunities that would provide us with access to new technology, geography or business adjacency that would make strong strategic sense and leverage our expertise in science and technology. We have the financial flexibility to invest in both external business development activities, as well as our organic growth programs. With that, I'll turn the call back over to Doug.